The Latest Headlines at American Banking and Market News
Acadia Healthcare (NASDAQ:ACHC) Hits New 52-Week Low on Analyst Downgrade
Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) hit a new 52-week low on Friday after StockNews.com downgraded the stock from a hold rating to a sell rating. The company traded as low as $65.67 and last traded... More of this article »
Starbucks (NASDAQ:SBUX) Shares Down 1.6% After Analyst Downgrade
Starbucks Co. (NASDAQ:SBUX – Get Free Report)’s share price was down 1.6% on Friday after HSBC lowered their price target on the stock from $107.00 to $84.00. HSBC currently has a hold rating on the stock. Starbucks traded... More of this article »
Barrick Gold Co. Expected to Earn Q3 2024 Earnings of $0.47 Per Share (TSE:ABX)
Barrick Gold Co. (TSE:ABX – Free Report) (NYSE:ABX) – Stock analysts at Raymond James upped their Q3 2024 earnings estimates for Barrick Gold in a report issued on Wednesday, May 1st. Raymond James analyst B. Macarthur... More of this article »
Morgan Stanley to Post Q3 2024 Earnings of $1.61 Per Share, Zacks Research Forecasts (NYSE:MS)
Morgan Stanley (NYSE:MS – Free Report) – Equities researchers at Zacks Research lifted their Q3 2024 earnings per share estimates for shares of Morgan Stanley in a research note issued to investors on Tuesday, April... More of this article »
Zoetis (NYSE:ZTS) Shares Up 0.5% Following Earnings Beat
Zoetis Inc. (NYSE:ZTS – Get Free Report) shares shot up 0.5% on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $171.69 and last traded at $168.00. 948,938 shares were traded... More of this article »
CGI Group, Inc. (TSE:GIB) Expected to Post Q3 2024 Earnings of $1.94 Per Share
CGI Group, Inc. (TSE:GIB – Free Report) – Stock analysts at National Bank Financial issued their Q3 2024 earnings estimates for shares of CGI Group in a research note issued on Wednesday, May 1st. National Bank Financial... More of this article »
Q3 2024 EPS Estimates for The Duckhorn Portfolio, Inc. Cut by Analyst (NYSE:NAPA)
The Duckhorn Portfolio, Inc. (NYSE:NAPA – Free Report) – Investment analysts at Wedbush decreased their Q3 2024 EPS estimates for Duckhorn Portfolio in a research note issued to investors on Wednesday, May 1st. Wedbush... More of this article »
QUALCOMM (NASDAQ:QCOM) Stock Price Down 0.9% Following Insider Selling
Shares of QUALCOMM Incorporated (NASDAQ:QCOM – Get Free Report) were down 0.9% during trading on Friday after an insider sold shares in the company. The company traded as low as $177.91 and last traded at $178.43. Approximately... More of this article »
Apple (NASDAQ:AAPL) Stock Price Up 6.6% on Earnings Beat
Apple Inc. (NASDAQ:AAPL – Get Free Report) shares were up 6.6% on Friday following a stronger than expected earnings report. The stock traded as high as $187.00 and last traded at $184.51. Approximately 67,264,407 shares were... More of this article »
Q3 2024 Earnings Estimate for SiteOne Landscape Supply, Inc. Issued By William Blair (NYSE:SITE)
SiteOne Landscape Supply, Inc. (NYSE:SITE – Free Report) – Research analysts at William Blair lifted their Q3 2024 earnings per share (EPS) estimates for shares of SiteOne Landscape Supply in a research report issued... More of this article »
Rave Restaurant Group (NASDAQ:RAVE) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com assumed coverage on shares of Rave Restaurant Group (NASDAQ:RAVE – Get Free Report) in a research note issued to investors on Saturday. The firm set a “buy” rating on the restaurant operator’s... More of this article »
Q3 2024 EPS Estimates for Douglas Dynamics, Inc. (NYSE:PLOW) Lowered by Analyst
Douglas Dynamics, Inc. (NYSE:PLOW – Free Report) – Sidoti Csr cut their Q3 2024 EPS estimates for Douglas Dynamics in a research report issued on Tuesday, April 30th. Sidoti Csr analyst G. Burns now anticipates that... More of this article »
StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)
Stock analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the specialty pharmaceutical company’s... More of this article »